Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1330678
European Journal of Endocrinology, Vol 133, Issue 6, 678-679
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohlsson, C
Right arrow Articles by Jennische, E
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ohlsson, C
Right arrow Articles by Jennische, E

Effects in skeletal muscle of supraphysiological growth hormone stimulation

C Ohlsson and E Jennische

Research Centre for Endocrinology and Metabolism, Department of Internal Medicine, Sahlgrenska Hospital, Göteborg, Sweden: Department of Anatomy and Cell Biology, University of Göteborg, Göteborg, Sweden

The introduction of recombinant growth hormone (GH) has increased the therapeutic use of GH. The most common indication for GH replacement therapy is still the treatment of children with different growth disorders. However, promising studies demonstrating positive effects of GH in GH-deficient adults have been presented and GH treatment of GH-deficient adults is now approved by several European countries (1). This predicts that the number of patients on GH replacement therapy will increase. Unfortunately, parallel with the increased prescription of GH, an increase in the abuse of GH is also suspected. It is still impossible to detect whether an athlete is abusing GH. The reason for this is that recombinant GH has an identical amino acid sequence to the predominant endogenous GH form, the 22-kD




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L.-L. Norrman, G. Johannsson, K. S. Sunnerhagen, and J. Svensson
Baseline Characteristics and the Effects of Two Years of Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency Previously Treated for Acromegaly
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2531 - 2538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Sinha-Hikim, J. Artaza, L. Woodhouse, N. Gonzalez-Cadavid, A. B. Singh, M. I. Lee, T. W. Storer, R. Casaburi, R. Shen, and S. Bhasin
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E154 - E164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.